nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—ANXA2—osteoporosis	0.0312	0.0791	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—FGA—osteoporosis	0.0132	0.0334	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—TLN1—osteoporosis	0.0131	0.0331	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—WDR1—osteoporosis	0.0127	0.0322	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.0121	0.0306	CbGpPWpGaD
Tranexamic Acid—PLG—Blood Clotting Cascade—FGB—osteoporosis	0.012	0.0304	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—RAP1A—osteoporosis	0.0108	0.0273	CbGpPWpGaD
Tranexamic Acid—PLG—Activation of Matrix Metalloproteinases—CTSK—osteoporosis	0.0107	0.0271	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—CAP1—osteoporosis	0.01	0.0254	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PRDX3—osteoporosis	0.00974	0.0247	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00955	0.0242	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGA—osteoporosis	0.00786	0.0199	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—PLEK—osteoporosis	0.00729	0.0185	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FGB—osteoporosis	0.00715	0.0181	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.00694	0.0176	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TLN1—osteoporosis	0.00628	0.0159	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VCL—osteoporosis	0.0062	0.0157	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00598	0.0152	CbGpPWpGaD
Tranexamic Acid—PLG—Orphan transporters—ANXA2—osteoporosis	0.00591	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.0059	0.015	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—AGER—osteoporosis	0.00571	0.0145	CbGpPWpGaD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—IGF1—osteoporosis	0.00564	0.0143	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00563	0.0143	CbGpPWpGaD
Tranexamic Acid—PLG—Complement and Coagulation Cascades—FGB—osteoporosis	0.00545	0.0138	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CTSK—osteoporosis	0.00471	0.012	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—FGA—osteoporosis	0.0047	0.0119	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.00447	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00445	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—FGB—osteoporosis	0.00427	0.0108	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—IBSP—osteoporosis	0.00427	0.0108	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—osteoporosis	0.00409	0.0104	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00407	0.0103	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.0036	0.00914	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00353	0.00896	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—osteoporosis	0.00333	0.00845	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00323	0.0082	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—GPX1—osteoporosis	0.00318	0.00806	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—MTHFR—osteoporosis	0.00293	0.00744	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—WDR1—osteoporosis	0.0029	0.00736	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.00279	0.00706	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00275	0.00697	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—osteoporosis	0.00265	0.00671	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—GPX1—osteoporosis	0.00252	0.0064	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—SPP1—osteoporosis	0.00243	0.00616	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00233	0.00591	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.0023	0.00582	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—CAP1—osteoporosis	0.00229	0.00581	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—TNF—osteoporosis	0.00225	0.00571	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL1B—osteoporosis	0.00214	0.00542	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—P4HB—osteoporosis	0.00208	0.00528	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.00208	0.00528	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—COL1A2—osteoporosis	0.00205	0.00519	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CTSK—osteoporosis	0.00198	0.00501	CbGpPWpGaD
Tranexamic Acid—PLG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—osteoporosis	0.00194	0.00492	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—IGF1—osteoporosis	0.00193	0.0049	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.00189	0.00481	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CCT2—osteoporosis	0.00189	0.00479	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.00184	0.00467	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—MGLL—osteoporosis	0.00182	0.00462	CbGpPWpGaD
Tranexamic Acid—PLG—amb2 Integrin signaling—IL6—osteoporosis	0.00182	0.00461	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KL—osteoporosis	0.00181	0.00458	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGA—osteoporosis	0.00181	0.00458	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL1B—osteoporosis	0.00174	0.00441	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—BMP2—osteoporosis	0.00168	0.00426	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PLEK—osteoporosis	0.00167	0.00422	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ANXA2—osteoporosis	0.00167	0.00422	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—FGB—osteoporosis	0.00164	0.00417	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—TUBA1B—osteoporosis	0.00161	0.00408	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoporosis	0.00158	0.004	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—COL1A1—osteoporosis	0.00157	0.00399	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—TNF—osteoporosis	0.00155	0.00394	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00144	0.00366	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TLN1—osteoporosis	0.00144	0.00364	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—VCL—osteoporosis	0.00142	0.00359	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ADCY5—osteoporosis	0.00142	0.00359	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL1B—osteoporosis	0.00138	0.00351	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—SPP1—osteoporosis	0.00137	0.00347	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—RPL24—osteoporosis	0.00129	0.00326	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TNF—osteoporosis	0.00126	0.0032	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—IL6—osteoporosis	0.00125	0.00318	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IRS2—osteoporosis	0.00124	0.00314	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAP1A—osteoporosis	0.00118	0.003	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—TGFB1—osteoporosis	0.00116	0.00294	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—TLN1—osteoporosis	0.00113	0.00286	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.0011	0.0028	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—REN—osteoporosis	0.00109	0.00275	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IRS1—osteoporosis	0.00108	0.00274	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—FGA—osteoporosis	0.00107	0.00272	CbGpPWpGaD
Tranexamic Acid—Cramp muscle—Estradiol—osteoporosis	0.00105	0.00174	CcSEcCtD
Tranexamic Acid—Discomfort—Calcitriol—osteoporosis	0.00105	0.00174	CcSEcCtD
Tranexamic Acid—Back pain—Ethinyl Estradiol—osteoporosis	0.00105	0.00173	CcSEcCtD
Tranexamic Acid—Angiopathy—Pamidronate—osteoporosis	0.00104	0.00172	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Ibandronate—osteoporosis	0.00104	0.00172	CcSEcCtD
Tranexamic Acid—Immune system disorder—Pamidronate—osteoporosis	0.00104	0.00172	CcSEcCtD
Tranexamic Acid—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.00104	0.00172	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Pamidronate—osteoporosis	0.00104	0.00171	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Etidronic acid—osteoporosis	0.00104	0.00171	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Raloxifene—osteoporosis	0.00103	0.00171	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00103	0.0017	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Ibandronate—osteoporosis	0.00102	0.00169	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Calcitriol—osteoporosis	0.00102	0.00169	CcSEcCtD
Tranexamic Acid—PLG—Folate Metabolism—IL6—osteoporosis	0.00102	0.00258	CbGpPWpGaD
Tranexamic Acid—Back pain—Risedronate—osteoporosis	0.00102	0.00168	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—SPP1—osteoporosis	0.00102	0.00258	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—IL6R—osteoporosis	0.00102	0.00258	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Risedronate—osteoporosis	0.00101	0.00167	CcSEcCtD
Tranexamic Acid—Nausea—Ergocalciferol—osteoporosis	0.00101	0.00166	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—TNF—osteoporosis	0.001	0.00254	CbGpPWpGaD
Tranexamic Acid—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.001	0.00166	CcSEcCtD
Tranexamic Acid—Abdominal pain—Etidronic acid—osteoporosis	0.000994	0.00164	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000991	0.00164	CcSEcCtD
Tranexamic Acid—Eye disorder—Zoledronate—osteoporosis	0.000982	0.00162	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—FGB—osteoporosis	0.000977	0.00248	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000976	0.00161	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Zoledronate—osteoporosis	0.000975	0.00161	CcSEcCtD
Tranexamic Acid—Flushing—Zoledronate—osteoporosis	0.000975	0.00161	CcSEcCtD
Tranexamic Acid—Visual impairment—Conjugated Estrogens—osteoporosis	0.000975	0.00161	CcSEcCtD
Tranexamic Acid—Malaise—Ethinyl Estradiol—osteoporosis	0.000974	0.00161	CcSEcCtD
Tranexamic Acid—Anaemia—Risedronate—osteoporosis	0.000974	0.00161	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Estradiol—osteoporosis	0.00097	0.0016	CcSEcCtD
Tranexamic Acid—Back pain—Pamidronate—osteoporosis	0.000969	0.0016	CcSEcCtD
Tranexamic Acid—Muscle spasms—Pamidronate—osteoporosis	0.000963	0.00159	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.00096	0.00159	CcSEcCtD
Tranexamic Acid—Dyspepsia—Estropipate—osteoporosis	0.000958	0.00158	CcSEcCtD
Tranexamic Acid—Angiopathy—Zoledronate—osteoporosis	0.000953	0.00157	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00095	0.00157	CcSEcCtD
Tranexamic Acid—Immune system disorder—Zoledronate—osteoporosis	0.000949	0.00157	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Zoledronate—osteoporosis	0.000947	0.00156	CcSEcCtD
Tranexamic Acid—Eye disorder—Conjugated Estrogens—osteoporosis	0.000946	0.00156	CcSEcCtD
Tranexamic Acid—Dyspepsia—Alendronate—osteoporosis	0.000943	0.00156	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Estropipate—osteoporosis	0.000939	0.00155	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000939	0.00155	CcSEcCtD
Tranexamic Acid—Arrhythmia—Zoledronate—osteoporosis	0.000939	0.00155	CcSEcCtD
Tranexamic Acid—Fatigue—Estropipate—osteoporosis	0.000938	0.00155	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.00093	0.00154	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Pamidronate—osteoporosis	0.000929	0.00153	CcSEcCtD
Tranexamic Acid—Dyspepsia—Raloxifene—osteoporosis	0.000928	0.00153	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Etidronic acid—osteoporosis	0.000926	0.00153	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Risedronate—osteoporosis	0.000926	0.00153	CcSEcCtD
Tranexamic Acid—Anaemia—Pamidronate—osteoporosis	0.000926	0.00153	CcSEcCtD
Tranexamic Acid—Dyspepsia—Ibandronate—osteoporosis	0.000918	0.00152	CcSEcCtD
Tranexamic Acid—Angiopathy—Conjugated Estrogens—osteoporosis	0.000918	0.00152	CcSEcCtD
Tranexamic Acid—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000914	0.00151	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000912	0.00151	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00091	0.0015	CcSEcCtD
Tranexamic Acid—Discomfort—Ethinyl Estradiol—osteoporosis	0.000909	0.0015	CcSEcCtD
Tranexamic Acid—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000904	0.00149	CcSEcCtD
Tranexamic Acid—Malaise—Pamidronate—osteoporosis	0.000903	0.00149	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000901	0.00149	CcSEcCtD
Tranexamic Acid—Fatigue—Ibandronate—osteoporosis	0.000899	0.00149	CcSEcCtD
Tranexamic Acid—Chest pain—Risedronate—osteoporosis	0.000897	0.00148	CcSEcCtD
Tranexamic Acid—Myalgia—Risedronate—osteoporosis	0.000897	0.00148	CcSEcCtD
Tranexamic Acid—Arthralgia—Risedronate—osteoporosis	0.000897	0.00148	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Estropipate—osteoporosis	0.00089	0.00147	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Estradiol—osteoporosis	0.000889	0.00147	CcSEcCtD
Tranexamic Acid—Back pain—Zoledronate—osteoporosis	0.000885	0.00146	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Estradiol—osteoporosis	0.000884	0.00146	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Alendronate—osteoporosis	0.000883	0.00146	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Pamidronate—osteoporosis	0.00088	0.00145	CcSEcCtD
Tranexamic Acid—Muscle spasms—Zoledronate—osteoporosis	0.000879	0.00145	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Alendronate—osteoporosis	0.000876	0.00145	CcSEcCtD
Tranexamic Acid—Convulsion—Pamidronate—osteoporosis	0.000868	0.00143	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000865	0.00143	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Raloxifene—osteoporosis	0.000862	0.00142	CcSEcCtD
Tranexamic Acid—Diarrhoea—Etidronic acid—osteoporosis	0.00086	0.00142	CcSEcCtD
Tranexamic Acid—Abdominal pain—Estropipate—osteoporosis	0.00086	0.00142	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Ibandronate—osteoporosis	0.00086	0.00142	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SOST—osteoporosis	0.00086	0.00218	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000858	0.00218	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Ibandronate—osteoporosis	0.000853	0.00141	CcSEcCtD
Tranexamic Acid—Arthralgia—Pamidronate—osteoporosis	0.000853	0.00141	CcSEcCtD
Tranexamic Acid—Myalgia—Pamidronate—osteoporosis	0.000853	0.00141	CcSEcCtD
Tranexamic Acid—Back pain—Conjugated Estrogens—osteoporosis	0.000852	0.00141	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Zoledronate—osteoporosis	0.000849	0.0014	CcSEcCtD
Tranexamic Acid—Abdominal pain—Alendronate—osteoporosis	0.000847	0.0014	CcSEcCtD
Tranexamic Acid—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000847	0.0014	CcSEcCtD
Tranexamic Acid—Sinusitis—Estradiol—osteoporosis	0.000846	0.0014	CcSEcCtD
Tranexamic Acid—Anaemia—Zoledronate—osteoporosis	0.000845	0.0014	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Risedronate—osteoporosis	0.000843	0.00139	CcSEcCtD
Tranexamic Acid—Discomfort—Pamidronate—osteoporosis	0.000842	0.00139	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Calcitriol—osteoporosis	0.000835	0.00138	CcSEcCtD
Tranexamic Acid—Abdominal pain—Raloxifene—osteoporosis	0.000833	0.00138	CcSEcCtD
Tranexamic Acid—Malaise—Zoledronate—osteoporosis	0.000825	0.00136	CcSEcCtD
Tranexamic Acid—Abdominal pain—Ibandronate—osteoporosis	0.000825	0.00136	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000823	0.00209	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Pamidronate—osteoporosis	0.000817	0.00135	CcSEcCtD
Tranexamic Acid—Haemoglobin—Estradiol—osteoporosis	0.000814	0.00134	CcSEcCtD
Tranexamic Acid—Haemorrhage—Estradiol—osteoporosis	0.00081	0.00134	CcSEcCtD
Tranexamic Acid—PLG—Selenium Micronutrient Network—IL6—osteoporosis	0.00081	0.00205	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Calcitriol—osteoporosis	0.000807	0.00133	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Zoledronate—osteoporosis	0.000804	0.00133	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Estropipate—osteoporosis	0.000802	0.00132	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Pamidronate—osteoporosis	0.000801	0.00132	CcSEcCtD
Tranexamic Acid—Vomiting—Etidronic acid—osteoporosis	0.0008	0.00132	CcSEcCtD
Tranexamic Acid—Convulsion—Zoledronate—osteoporosis	0.000793	0.00131	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Alendronate—osteoporosis	0.000789	0.0013	CcSEcCtD
Tranexamic Acid—Headache—Etidronic acid—osteoporosis	0.000788	0.0013	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000783	0.00129	CcSEcCtD
Tranexamic Acid—Asthenia—Estropipate—osteoporosis	0.000781	0.00129	CcSEcCtD
Tranexamic Acid—Visual impairment—Estradiol—osteoporosis	0.00078	0.00129	CcSEcCtD
Tranexamic Acid—Chest pain—Zoledronate—osteoporosis	0.000779	0.00129	CcSEcCtD
Tranexamic Acid—Arthralgia—Zoledronate—osteoporosis	0.000779	0.00129	CcSEcCtD
Tranexamic Acid—Myalgia—Zoledronate—osteoporosis	0.000779	0.00129	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CALCR—osteoporosis	0.000777	0.00197	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTH1R—osteoporosis	0.000777	0.00197	CbGpPWpGaD
Tranexamic Acid—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000774	0.00128	CcSEcCtD
Tranexamic Acid—Discomfort—Zoledronate—osteoporosis	0.000769	0.00127	CcSEcCtD
Tranexamic Acid—Asthenia—Alendronate—osteoporosis	0.000769	0.00127	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Ibandronate—osteoporosis	0.000769	0.00127	CcSEcCtD
Tranexamic Acid—Dyspnoea—Risedronate—osteoporosis	0.000766	0.00127	CcSEcCtD
Tranexamic Acid—Hypotension—Pamidronate—osteoporosis	0.000764	0.00126	CcSEcCtD
Tranexamic Acid—Convulsion—Conjugated Estrogens—osteoporosis	0.000763	0.00126	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000761	0.00126	CcSEcCtD
Tranexamic Acid—Fatigue—Ethinyl Estradiol—osteoporosis	0.00076	0.00126	CcSEcCtD
Tranexamic Acid—Dyspepsia—Risedronate—osteoporosis	0.000757	0.00125	CcSEcCtD
Tranexamic Acid—Eye disorder—Estradiol—osteoporosis	0.000757	0.00125	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Calcitriol—osteoporosis	0.000752	0.00124	CcSEcCtD
Tranexamic Acid—Flushing—Estradiol—osteoporosis	0.000752	0.00124	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Estradiol—osteoporosis	0.000752	0.00124	CcSEcCtD
Tranexamic Acid—Chest pain—Conjugated Estrogens—osteoporosis	0.00075	0.00124	CcSEcCtD
Tranexamic Acid—Arthralgia—Conjugated Estrogens—osteoporosis	0.00075	0.00124	CcSEcCtD
Tranexamic Acid—Myalgia—Conjugated Estrogens—osteoporosis	0.00075	0.00124	CcSEcCtD
Tranexamic Acid—Asthenia—Ibandronate—osteoporosis	0.000748	0.00124	CcSEcCtD
Tranexamic Acid—Nausea—Etidronic acid—osteoporosis	0.000747	0.00123	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Zoledronate—osteoporosis	0.000747	0.00123	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000745	0.00123	CcSEcCtD
Tranexamic Acid—Diarrhoea—Estropipate—osteoporosis	0.000744	0.00123	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Risedronate—osteoporosis	0.000742	0.00123	CcSEcCtD
Tranexamic Acid—Fatigue—Risedronate—osteoporosis	0.000741	0.00122	CcSEcCtD
Tranexamic Acid—Angiopathy—Estradiol—osteoporosis	0.000735	0.00121	CcSEcCtD
Tranexamic Acid—Diarrhoea—Alendronate—osteoporosis	0.000733	0.00121	CcSEcCtD
Tranexamic Acid—Asthenia—Calcitriol—osteoporosis	0.000733	0.00121	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Zoledronate—osteoporosis	0.000732	0.00121	CcSEcCtD
Tranexamic Acid—Immune system disorder—Estradiol—osteoporosis	0.000731	0.00121	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Estradiol—osteoporosis	0.00073	0.00121	CcSEcCtD
Tranexamic Acid—Dyspnoea—Pamidronate—osteoporosis	0.000729	0.0012	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000727	0.0012	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000721	0.00119	CcSEcCtD
Tranexamic Acid—Diarrhoea—Raloxifene—osteoporosis	0.000721	0.00119	CcSEcCtD
Tranexamic Acid—Dyspepsia—Pamidronate—osteoporosis	0.000719	0.00119	CcSEcCtD
Tranexamic Acid—Dizziness—Estropipate—osteoporosis	0.000719	0.00119	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000719	0.00119	CcSEcCtD
Tranexamic Acid—Diarrhoea—Ibandronate—osteoporosis	0.000714	0.00118	CcSEcCtD
Tranexamic Acid—Dizziness—Alendronate—osteoporosis	0.000709	0.00117	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000706	0.00117	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000705	0.00116	CcSEcCtD
Tranexamic Acid—Fatigue—Pamidronate—osteoporosis	0.000705	0.00116	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Risedronate—osteoporosis	0.000703	0.00116	CcSEcCtD
Tranexamic Acid—Diarrhoea—Calcitriol—osteoporosis	0.000699	0.00115	CcSEcCtD
Tranexamic Acid—Hypotension—Zoledronate—osteoporosis	0.000698	0.00115	CcSEcCtD
Tranexamic Acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000697	0.00115	CcSEcCtD
Tranexamic Acid—Dizziness—Raloxifene—osteoporosis	0.000697	0.00115	CcSEcCtD
Tranexamic Acid—Vomiting—Estropipate—osteoporosis	0.000692	0.00114	CcSEcCtD
Tranexamic Acid—Dizziness—Ibandronate—osteoporosis	0.00069	0.00114	CcSEcCtD
Tranexamic Acid—Back pain—Estradiol—osteoporosis	0.000682	0.00113	CcSEcCtD
Tranexamic Acid—Headache—Estropipate—osteoporosis	0.000682	0.00113	CcSEcCtD
Tranexamic Acid—Vomiting—Alendronate—osteoporosis	0.000681	0.00112	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.00068	0.00112	CcSEcCtD
Tranexamic Acid—Abdominal pain—Risedronate—osteoporosis	0.00068	0.00112	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACE—osteoporosis	0.000678	0.00172	CbGpPWpGaD
Tranexamic Acid—Muscle spasms—Estradiol—osteoporosis	0.000678	0.00112	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Pamidronate—osteoporosis	0.000673	0.00111	CcSEcCtD
Tranexamic Acid—Hypotension—Conjugated Estrogens—osteoporosis	0.000672	0.00111	CcSEcCtD
Tranexamic Acid—Headache—Alendronate—osteoporosis	0.000671	0.00111	CcSEcCtD
Tranexamic Acid—Vomiting—Raloxifene—osteoporosis	0.00067	0.00111	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Pamidronate—osteoporosis	0.000668	0.0011	CcSEcCtD
Tranexamic Acid—Dyspnoea—Zoledronate—osteoporosis	0.000666	0.0011	CcSEcCtD
Tranexamic Acid—Vomiting—Ibandronate—osteoporosis	0.000663	0.0011	CcSEcCtD
Tranexamic Acid—Headache—Raloxifene—osteoporosis	0.00066	0.00109	CcSEcCtD
Tranexamic Acid—Dyspepsia—Zoledronate—osteoporosis	0.000657	0.00109	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000655	0.00108	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Estradiol—osteoporosis	0.000654	0.00108	CcSEcCtD
Tranexamic Acid—Headache—Ibandronate—osteoporosis	0.000654	0.00108	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00065	0.00107	CcSEcCtD
Tranexamic Acid—Vomiting—Calcitriol—osteoporosis	0.000649	0.00107	CcSEcCtD
Tranexamic Acid—Nausea—Estropipate—osteoporosis	0.000646	0.00107	CcSEcCtD
Tranexamic Acid—Abdominal pain—Pamidronate—osteoporosis	0.000646	0.00107	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000645	0.00106	CcSEcCtD
Tranexamic Acid—Fatigue—Zoledronate—osteoporosis	0.000644	0.00106	CcSEcCtD
Tranexamic Acid—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000641	0.00106	CcSEcCtD
Tranexamic Acid—Headache—Calcitriol—osteoporosis	0.00064	0.00106	CcSEcCtD
Tranexamic Acid—Nausea—Alendronate—osteoporosis	0.000636	0.00105	CcSEcCtD
Tranexamic Acid—Malaise—Estradiol—osteoporosis	0.000636	0.00105	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Risedronate—osteoporosis	0.000633	0.00105	CcSEcCtD
Tranexamic Acid—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000633	0.00104	CcSEcCtD
Tranexamic Acid—Asthenia—Ethinyl Estradiol—osteoporosis	0.000633	0.00104	CcSEcCtD
Tranexamic Acid—Nausea—Raloxifene—osteoporosis	0.000626	0.00103	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000621	0.00102	CcSEcCtD
Tranexamic Acid—Fatigue—Conjugated Estrogens—osteoporosis	0.00062	0.00102	CcSEcCtD
Tranexamic Acid—Nausea—Ibandronate—osteoporosis	0.00062	0.00102	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Estradiol—osteoporosis	0.00062	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—MGLL—osteoporosis	0.000618	0.00157	CbGpPWpGaD
Tranexamic Acid—Asthenia—Risedronate—osteoporosis	0.000617	0.00102	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Zoledronate—osteoporosis	0.000615	0.00102	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Zoledronate—osteoporosis	0.00061	0.00101	CcSEcCtD
Tranexamic Acid—Nausea—Calcitriol—osteoporosis	0.000607	0.001	CcSEcCtD
Tranexamic Acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000603	0.000996	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LRP5—osteoporosis	0.000603	0.00153	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Pamidronate—osteoporosis	0.000602	0.000994	CcSEcCtD
Tranexamic Acid—Chest pain—Estradiol—osteoporosis	0.0006	0.000991	CcSEcCtD
Tranexamic Acid—Myalgia—Estradiol—osteoporosis	0.0006	0.000991	CcSEcCtD
Tranexamic Acid—Arthralgia—Estradiol—osteoporosis	0.0006	0.000991	CcSEcCtD
Tranexamic Acid—Discomfort—Estradiol—osteoporosis	0.000593	0.000979	CcSEcCtD
Tranexamic Acid—Abdominal pain—Zoledronate—osteoporosis	0.00059	0.000974	CcSEcCtD
Tranexamic Acid—Diarrhoea—Risedronate—osteoporosis	0.000588	0.000971	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000588	0.000971	CcSEcCtD
Tranexamic Acid—Asthenia—Pamidronate—osteoporosis	0.000586	0.000968	CcSEcCtD
Tranexamic Acid—Dizziness—Ethinyl Estradiol—osteoporosis	0.000583	0.000963	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LRP6—osteoporosis	0.000577	0.00146	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Estradiol—osteoporosis	0.000575	0.00095	CcSEcCtD
Tranexamic Acid—Dizziness—Risedronate—osteoporosis	0.000569	0.000939	CcSEcCtD
Tranexamic Acid—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000568	0.000938	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Estradiol—osteoporosis	0.000564	0.000932	CcSEcCtD
Tranexamic Acid—Vomiting—Ethinyl Estradiol—osteoporosis	0.000561	0.000926	CcSEcCtD
Tranexamic Acid—Diarrhoea—Pamidronate—osteoporosis	0.000559	0.000923	CcSEcCtD
Tranexamic Acid—Headache—Ethinyl Estradiol—osteoporosis	0.000552	0.000912	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Zoledronate—osteoporosis	0.00055	0.000908	CcSEcCtD
Tranexamic Acid—Vomiting—Risedronate—osteoporosis	0.000547	0.000903	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000541	0.00137	CbGpPWpGaD
Tranexamic Acid—Dizziness—Pamidronate—osteoporosis	0.00054	0.000892	CcSEcCtD
Tranexamic Acid—Headache—Risedronate—osteoporosis	0.000539	0.000889	CcSEcCtD
Tranexamic Acid—Asthenia—Zoledronate—osteoporosis	0.000536	0.000884	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00053	0.000874	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000524	0.000865	CcSEcCtD
Tranexamic Acid—Nausea—Ethinyl Estradiol—osteoporosis	0.000524	0.000865	CcSEcCtD
Tranexamic Acid—Vomiting—Pamidronate—osteoporosis	0.00052	0.000858	CcSEcCtD
Tranexamic Acid—Asthenia—Conjugated Estrogens—osteoporosis	0.000516	0.000852	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000514	0.0013	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Estradiol—osteoporosis	0.000513	0.000847	CcSEcCtD
Tranexamic Acid—Headache—Pamidronate—osteoporosis	0.000512	0.000845	CcSEcCtD
Tranexamic Acid—Diarrhoea—Zoledronate—osteoporosis	0.000511	0.000843	CcSEcCtD
Tranexamic Acid—Nausea—Risedronate—osteoporosis	0.000511	0.000843	CcSEcCtD
Tranexamic Acid—Dyspepsia—Estradiol—osteoporosis	0.000506	0.000836	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Estradiol—osteoporosis	0.000497	0.00082	CcSEcCtD
Tranexamic Acid—Fatigue—Estradiol—osteoporosis	0.000496	0.000819	CcSEcCtD
Tranexamic Acid—Dizziness—Zoledronate—osteoporosis	0.000494	0.000815	CcSEcCtD
Tranexamic Acid—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000492	0.000812	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—TLN1—osteoporosis	0.000487	0.00123	CbGpPWpGaD
Tranexamic Acid—Nausea—Pamidronate—osteoporosis	0.000485	0.000802	CcSEcCtD
Tranexamic Acid—Dizziness—Conjugated Estrogens—osteoporosis	0.000475	0.000785	CcSEcCtD
Tranexamic Acid—Vomiting—Zoledronate—osteoporosis	0.000475	0.000784	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Estradiol—osteoporosis	0.000474	0.000783	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Estradiol—osteoporosis	0.00047	0.000777	CcSEcCtD
Tranexamic Acid—Headache—Zoledronate—osteoporosis	0.000468	0.000772	CcSEcCtD
Tranexamic Acid—Vomiting—Conjugated Estrogens—osteoporosis	0.000457	0.000755	CcSEcCtD
Tranexamic Acid—Abdominal pain—Estradiol—osteoporosis	0.000455	0.000751	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—IL6—osteoporosis	0.000453	0.00115	CbGpPWpGaD
Tranexamic Acid—Headache—Conjugated Estrogens—osteoporosis	0.00045	0.000744	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—TGFB1—osteoporosis	0.000446	0.00113	CbGpPWpGaD
Tranexamic Acid—Nausea—Zoledronate—osteoporosis	0.000443	0.000732	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IGF1—osteoporosis	0.000442	0.00112	CbGpPWpGaD
Tranexamic Acid—Nausea—Conjugated Estrogens—osteoporosis	0.000427	0.000705	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Estradiol—osteoporosis	0.000424	0.0007	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—LEP—osteoporosis	0.000421	0.00107	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—P4HB—osteoporosis	0.00042	0.00106	CbGpPWpGaD
Tranexamic Acid—Asthenia—Estradiol—osteoporosis	0.000413	0.000682	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTH—osteoporosis	0.000408	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAP1A—osteoporosis	0.000401	0.00102	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CNR2—osteoporosis	0.000398	0.00101	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Estradiol—osteoporosis	0.000394	0.00065	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—NFATC1—osteoporosis	0.000392	0.000993	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—DKK1—osteoporosis	0.000388	0.000985	CbGpPWpGaD
Tranexamic Acid—Dizziness—Estradiol—osteoporosis	0.00038	0.000628	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—WNT1—osteoporosis	0.000374	0.000949	CbGpPWpGaD
Tranexamic Acid—Vomiting—Estradiol—osteoporosis	0.000366	0.000604	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FGA—osteoporosis	0.000364	0.000923	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—POMC—osteoporosis	0.000362	0.000917	CbGpPWpGaD
Tranexamic Acid—Headache—Estradiol—osteoporosis	0.00036	0.000595	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—IGF1—osteoporosis	0.000348	0.000882	CbGpPWpGaD
Tranexamic Acid—Nausea—Estradiol—osteoporosis	0.000342	0.000564	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PTHLH—osteoporosis	0.000338	0.000858	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BMP2—osteoporosis	0.000338	0.000858	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—FGB—osteoporosis	0.000331	0.00084	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PSMA2—osteoporosis	0.00032	0.000811	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PSMA5—osteoporosis	0.00032	0.000811	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000309	0.000783	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CALCA—osteoporosis	0.000298	0.000755	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KL—osteoporosis	0.000271	0.000686	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—TGFB1—osteoporosis	0.000265	0.000672	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ADCY5—osteoporosis	0.000212	0.000537	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—SPP1—osteoporosis	0.000205	0.00052	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS2—osteoporosis	0.000185	0.00047	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—LEP—osteoporosis	0.000181	0.00046	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ESR1—osteoporosis	0.000173	0.000439	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IRS1—osteoporosis	0.000162	0.00041	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—POMC—osteoporosis	0.000156	0.000395	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6R—osteoporosis	0.000152	0.000386	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IGF1—osteoporosis	0.00015	0.00038	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—osteoporosis	9.01e-05	0.000228	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TGFB1—osteoporosis	8.99e-05	0.000228	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL6—osteoporosis	6.77e-05	0.000172	CbGpPWpGaD
